Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.
about
The Role of Cardiolipin in Cardiovascular HealthPrevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.Dystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesSildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.Autophagy and skeletal muscles in sepsisDietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition.Cardiac anaplerosis in health and disease: food for thought.Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation.Mitochondrial vulnerability and increased susceptibility to nutrient-induced cytotoxicity in fibroblasts from leigh syndrome French canadian patients.Mice deleted for heart-type cytochrome c oxidase subunit 7a1 develop dilated cardiomyopathy.Mitochondrial dysfunctions during progression of dystrophic cardiomyopathyExclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathyThe NO/ONOO-cycle as the central cause of heart failure.NOTCH1-Dependent Nitric Oxide Signaling Deficiency in Hypoplastic Left Heart Syndrome Revealed Through Patient-Specific Phenotypes Detected in Bioengineered Cardiogenesis.Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy.
P2860
Q26798052-DAB49A0D-EB84-4EAF-8F3A-93A31F1F0F12Q30626615-6499D5BC-33CC-4CD7-A0A4-E63277AD3773Q33608478-D1DEA6AD-40F3-4EA8-8981-9E1935118100Q34279254-440E764F-500D-467A-BB0B-0F291225036AQ34442945-2272C018-EFBE-4386-8743-081C392EF7F4Q34767042-21D6EEF5-166B-429B-850C-7E4A04AF7BB9Q34808534-B8121777-82DF-403C-BAB1-7B4FF9F52565Q34854255-6D2BDB3B-F214-404B-AE10-A9F3F8BFBC73Q35218361-1FDB0AC6-B731-4915-A81D-9D84A90E1A5FQ35250813-FEEEF920-9E35-4932-B7D0-8A26613AF80CQ35822926-F311649E-C810-49F1-8030-482885B35114Q35850447-F98BC3CA-AD55-4710-8CBF-A4ECF6E354BBQ36908212-E2E4DD29-C0D0-406D-A838-2D40B5D7B83FQ37375441-DEB536A6-1E77-4381-A7D7-ED033D182507Q50458150-7A17A66C-6C28-4DD1-AB53-5455748C853FQ55002268-CE94E8C7-F60C-4F06-AAD5-E01B126288BF
P2860
Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@en
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@nl
type
label
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@en
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@nl
prefLabel
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@en
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@nl
P2093
P2860
P1476
Alterations in mitochondrial f ...... ons from the dystrophic heart.
@en
P2093
Alexis Ascah
Basil J Petrof
Bruce G Allen
Christian F Deschepper
Christine Des Rosiers
Maya Khairallah
Yan Burelle
P2860
P304
P356
10.1016/J.YJMCC.2009.09.004
P577
2009-09-18T00:00:00Z